Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Ligand acquires financial rights to portfolio of programs from Selexis

May 3, 2013

Tolero acquires worldwide license to Sanofi's alvocidib

May 3, 2013

Servier to use Afraxis' ESP Technology for drug discovery

May 3, 2013

Dana-Farber and Evotec form oncology collaboration focusing on epigenetic targets

May 3, 2013

Repros to collaborate with Northwestern University on phase II study of Proellex in breast cancer

May 2, 2013

Forma Therapeutics and Celgene to advance drugs targeting protein homeostasis

May 2, 2013

Almac Discovery licenses ALM-201 to Shin Poong in South Korea

May 2, 2013

Oxford BioTherapeutics and Boehringer Ingelheim to discover cancer antibody targets

May 2, 2013

Heptares Therapeutics achieves milestones in GPCR collaboration

May 2, 2013

Novartis initiates phase II trial of INC-280 triggering milestone payment to Incyte

April 30, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...